Drägerwerk AG & Co. KGaA (pref) (DRW3) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.026x

Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has a cash flow conversion efficiency ratio of -0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-38.08 Million ≈ $-44.51 Million USD) by net assets (€1.47 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Drägerwerk AG & Co. KGaA (pref) - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Drägerwerk AG & Co. KGaA (pref) total liabilities for a breakdown of total debt and financial obligations.

Drägerwerk AG & Co. KGaA (pref) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Reysas Tasimacilik ve Lojistik Ticaret AS
IS:RYSAS
0.045x
Shanghai Xinhua Media Co Ltd
SHG:600825
-0.002x
Beyondsoft Corp
SHE:002649
0.036x
Hunan Tyen Machinery Co Ltd A
SHG:600698
-0.042x
Zhejiang Oceanking Development Co Ltd
SHG:603213
0.067x
Xiamen 35Com Tech
SHE:300051
-0.004x
Pantoro Gold Ltd
AU:PNR
0.247x
NCR Voyix Corporation
NYSE:VYX
0.052x

Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (pref) (2013–2024)

The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Drägerwerk AG & Co. KGaA (pref) market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €1.54 Billion
≈ $1.80 Billion
€167.31 Million
≈ $195.60 Million
0.109x -19.11%
2023-12-31 €1.41 Billion
≈ $1.65 Billion
€189.68 Million
≈ $221.75 Million
0.135x +223.13%
2022-12-31 €1.32 Billion
≈ $1.54 Billion
€-144.23 Million
≈ $-168.62 Million
-0.109x -135.80%
2021-12-31 €1.26 Billion
≈ $1.47 Billion
€384.89 Million
≈ $449.97 Million
0.305x -31.37%
2020-12-31 €1.03 Billion
≈ $1.21 Billion
€459.98 Million
≈ $537.76 Million
0.445x +191.27%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€164.42 Million
≈ $192.22 Million
0.153x +3936.11%
2018-12-31 €1.08 Billion
≈ $1.26 Billion
€4.09 Million
≈ $4.78 Million
0.004x -97.18%
2017-12-31 €1.07 Billion
≈ $1.25 Billion
€143.34 Million
≈ $167.57 Million
0.134x -31.07%
2016-12-31 €1.00 Billion
≈ $1.17 Billion
€195.32 Million
≈ $228.35 Million
0.195x +361.89%
2015-12-31 €945.93 Million
≈ $1.11 Billion
€39.86 Million
≈ $46.60 Million
0.042x -79.90%
2014-12-31 €896.61 Million
≈ $1.05 Billion
€187.98 Million
≈ $219.77 Million
0.210x +150.33%
2013-12-31 €815.97 Million
≈ $953.95 Million
€68.34 Million
≈ $79.90 Million
0.084x --

About Drägerwerk AG & Co. KGaA (pref)

F:DRW3 Germany Medical Devices
Market Cap
$895.84 Million
€766.26 Million EUR
Market Cap Rank
#9608 Global
#1166 in Germany
Share Price
€89.10
Change (1 day)
+0.34%
52-Week Range
€60.20 - €98.90
All Time High
€99.80
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more